Cite
MLA Citation
Larysa Sanchez et al.. “Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma.” Therapeutic advances in hematology, vol. 12, 2021, p. . http://access.bl.uk/ark:/81055/vdc_100122732743.0x000015